11-6916 suporaef filter ss hr

3
Supor ® AEF 0.2 µm Intravenous Filter Air-eliminating filter set designed for 24-hour infusion drug delivery Features 0.2 µm Supor (polyethersulfone) membrane. Low protein binding. Compatible with all standard clinical infusion regimens, including those utilizing infusion and syringe pumps. Sterile and non-pyrogenic fluid pathway. Free of natural rubber latex. Non-phthalate fluid pathway. Benefits Reduces inadvertent particulate debris and eliminates entrained air that may be found in intravenous solutions for a maximum of 24 hours. Minimal adsorption to the membrane. Will not introduce undesirable extract- ables into the infusion preparation. Use with continuous infusions as well as with intermittent infusions or injections. 11.6916

Upload: vikasojha54706

Post on 03-Jun-2018

229 views

Category:

Documents


0 download

TRANSCRIPT

8/12/2019 11-6916 SuporAEF Filter SS HR

http://slidepdf.com/reader/full/11-6916-suporaef-filter-ss-hr 1/2

Supor® AEF 0.2 µm Intravenous Filter

Air-eliminating filter set designed for 24-hour infusion drug delivery

Features

0.2 µm Supor (polyethersulfone)

membrane.

Low protein binding.Compatible with all standard clinical

infusion regimens, including those

utilizing infusion and syringe pumps.

Sterile and non-pyrogenic fluid pathway.

Free of natural rubber latex. Non-phthalate

fluid pathway.

Benefits

Reduces inadvertent particulate debris

and eliminates entrained air that may

be found in intravenous solutions for

a maximum of 24 hours.

Minimal adsorption to the membrane.

Will not introduce undesirable extract-

ables into the infusion preparation.

Use with continuous infusions as well as

with intermittent infusions or injections.

11.6916

8/12/2019 11-6916 SuporAEF Filter SS HR

http://slidepdf.com/reader/full/11-6916-suporaef-filter-ss-hr 2/2

 The information provided in this literature was reviewed for accuracy at the time of publication. Product data may

be subject to change without notice. For current information consult your local Pall distributor or contact Pall directly.

© 2011, Pall Corporation. Pall, and Supor are trademarks of Pall Corporation. ® indicates a registered

trademark in the USA.  Filtration.Separation.Solution. is a service mark of Pall Corporation.

International Offices

Pall Corporation has offices and plants throughout the world in locations such as: Argentina, Australia, Austria,

Belgium, Brazil, Canada, China, France, Germany, India, Indonesia, Ireland, Italy, Japan, Korea, Malaysia, Mexico,

the Netherlands, New Zealand, Norway, Poland, Puerto Rico, Russia, Singapore, Spain, Sweden, Switzerland,

 Taiwan, Thailand, the United Kingdom, the United States, and Venezuela. Distributors in all major industrial areas

of the world.

 Visit us on the Web at www.pall.com

7/11, XK, GN11.6916 11.6916

United States

25 Harbor Park Drive

Port Washington, NY 11050

1.866.347.3428 toll free phone (USA)

1.516.484.5400 phone

Europe

Pall International Sàrl

 Avenue de Tivoli 3

1700 Fribourg, Switzerland

+41 (0)26 350 53 00 phone

+41 (0)26 350 53 53 fax

[email protected] email

Description 

Usage

Single patient use

24-hour maximum use

Can be used with continuous infusions or intermittent

infusions/ injections

Materials of Construction

Filter Media: 0.2 µm Supor (polyethersulfone) membrane

Filter Housing: Acrylic

 Air Elimination

 Two 0.02 µm hydrophobic membranes

Sterilization

Sterile and non-pyrogenic fluid pathway. Gamma sterilized.

Internal Volume of Filter

0.7 mL

Maximum Working Pressure

30 psi (1,500 mm Hg, 2 bar)

Bubble Point

≥ 46 psi (2,380 mm Hg, 3.1 bar)

Hold-up Volume Plus Tubing Extension

(where applicable)

 AEF1E - approximately 1.0 mL

 AEF1NTE - approximately 0.7 mL

Flow Rates 0.9% (w/v) Saline at 1 m Infusion

 AEF1E - approximately 9 mL/min.

 AEF1NTE - approximately 12 mL/min.

Bacterial Retention

Retentive of B. diminuta and meets USP 25/NF20

requirements for a sterilizing grade filter per ASTM F838-05

test methods.

Biological Safety Has been evaluated in accordance with USP Class VI-121ºC

plastic tests and/or relevant sections of the ISO 10993 series

of standards to ensure biological safety of the materials.

Inadvertent contamination of intravenous infusions can have serious consequences: 

• Particulate Contamination – Arises

from a variety of sources, intrinsically

in infusate and equipment, and

extrinsically due to manipulations.

Studies have demonstrated that

particles may cause phlebitis.1

• Entrained Air – Results from

degassing of solutions, incomplete

priming, or with disconnection.

Entrained air is especially

problematic on central line,

leading to air emboli.2

• Microbial Contamination – of

IV administration systems arises

inadvertently due to manipulations.3

Some bacteria can grow rapidly

in infusion fluids, increasing the

infection risk.4,5

Ordering Information 

Supor AEF low protein binding intravenous filter for 24-hour 

use, female luer inlet and male luer outlet.

Part

Number Description Pkg Qty

 AEF1E Supor AEF low protein binding Individually 50/caseintravenous filter set for 24-hour use, packagedinlet female luer connector, outletmicrobore tubing, slide clamp, andmale luer connector

 AEF1NTE Supor AEF low protein binding Individually 50/caseintravenous filter set for 24-hour use, packaged

inlet female luer connector and outletmale luer connector with rotating collar

References

1. Falchuk KH, Peterson L, McNeil BJ. New England Journal of Medicine, 1985; 312:78-82.

2. Coppa GF, Gouge TH, Hofstetter SR. J Parenteral Enteral Nutr .1981;5:166-8.

3. Groves MJ. Parenteral Technology Manual , 2nd ed., InterpharmPress, 1989.

4. Holmes, CJ, Kundsin RB, Ausman RK, Walter CW. J Clin Microbiol .1980; 12:725-31.

5. Bozzetti F, Bonfanti G, Regalia E. Nutri Clin Pract . 1990; 5:156-9.